Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

(2013) Roxana Mehran et al.   LANCET

Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation

(2012) Morten Schmidt et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

(2012) Marco Valgimigli et al.   CIRCULATION

Grabbing the Horns of a Dilemma

(2012) Neal S. Kleiman   CIRCULATION

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents

(2012) Sripal Bangalore et al.   CIRCULATION

Duration of Dual Antiplatelet Therapy and Long-Term Clinical Outcome After Coronary Drug-Eluting Stent Implantation

(2012) Tomohisa Tada et al.   Circulation-Cardiovascular Interventions

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials

(2012) Salvatore Cassese et al.   EUROPEAN HEART JOURNAL

A New Strategy for Discontinuation of Dual Antiplatelet Therapy

(2012) Byeong-Keuk Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Double Antiplatelet Therapy After Drug-Eluting Stent Implantation

(2012) Ignacio Ferreira-González et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation

(2011) M. Schmidt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevalence, Predictors, and Long-Term Prognosis of Premature Discontinuation of Oral Antiplatelet Therapy After Drug Eluting Stent Implantation

(2011) Roberta Rossini et al.   AMERICAN JOURNAL OF CARDIOLOGY

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

(2011) Hyeon-Cheol Gwon et al.   CIRCULATION

Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events

(2011) Morten Schmidt et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension

(2011) J. LaFleur et al.   HEART

The Danish National Prescription Registry

(2011) Helle Wallach Kildemoes et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

(2010) Laura Mauri et al.   AMERICAN HEART JOURNAL

Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation

(2010) Ignacio Ferreira-González et al.   CIRCULATION

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents

(2010) Seung-Jung Park et al.   NEW ENGLAND JOURNAL OF MEDICINE

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry

(2010) Lisette Jensen et al.   EuroIntervention

Existing data sources for clinical epidemiology: The Western Denmark Heart Registry

(2010) Morten Schmidt   Clinical Epidemiology

Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents

(2009) Dennis T. Ko et al.   AMERICAN HEART JOURNAL

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study

(2009) Robert A. Byrne et al.   AMERICAN HEART JOURNAL

Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation

(2009) Probal Roy et al.   AMERICAN JOURNAL OF CARDIOLOGY

Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients

(2009) Dong-Ho Shin et al.   AMERICAN JOURNAL OF CARDIOLOGY

Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation

(2009) Takeshi Kimura et al.   CIRCULATION

2-Year Clinical Outcomes After Implantation of Sirolimus-Eluting, Paclitaxel-Eluting, and Bare-Metal Coronary Stents

(2009) Anne Kaltoft et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE